Herceptin is a prescription drug used to treat certain kinds of breast and stomach cancer in adults. Learn about side effects and what to do about them.

A 73 year-old patient with a history of metastatic breast cancer was recently treated with Herceptin (trastuzumab) and developed congestive heart failure (CHF).

Find out all you need to know about Herceptin (trastuzumab) for early and more advanced HER2-positive breast cancer, including what to expect, outcomes, side effects, and more.

In discussing the trial results, ASCO spokesman Don Dizon noted Herceptin’s place in the history of oncology therapeutics. “More than a decade ago, Herceptin transformed the outlook for women with ...

Study results of more than 8,000 women worldwide who took the breast-cancer drug Herceptin ... "This observation suggests a dramatic and perhaps permanent perturbation of the natural history ...

Dennis Slamon, MD, PhD, talks about his involvement in the history of Herceptin. Dennis Slamon, MD, PhD, talked with CURE’s Elizabeth Whittington about his involvement in the history of Herceptin. A ...

Roche group’s Genentech emerged as the market leader in the HER2+ breast cancer drugs market in 2020LONDON, July 13, 2022 (GLOBE NEWSWIRE) -- The “HER2+ Breast Cancer – Global Drug Forecast ...

The first study to investigate the effect of the breast cancer drug trastuzumab (Herceptin) on heart and vascular function in elderly patients has found that it increases the risk of heart ...

The breast cancer drug Herceptin could cut the number of mastectomies and extend lives among the 44,000 breast cancer patients diagnosed in Britain each year.

A group of Staffordshire women who have breast cancer were campaigning throughout 2005/6 for a treatment drug, Herceptin, to be made available to them on the NHS. Amazingly, it was a complete ...

Hundreds of women who have been denied access to the breast-cancer drug Herceptin may now receive the life-saving treatment after the Court of Appeal ruled that an NHS trust had acted ...

NICE has a history of rowing with Roche over its breast cancer drugs, but peace has broken out in recent times – and now recommendation of a new use for Perjeta will make the NHS an early adopter. The ...